NASDAQ:TLRY   Tilray Brands, Inc.
The Play
TLRY has had a 30%+ pullback from the recent highs stemming from the December 2, 2022, recent legislation that was signed by President Biden. The strategy is to take advantage of a likely 10-15% rally in the short term.

Legislation: Highlights
After unanimous consent from the Senate, President Biden signed into law the Medical Marijuana and Cannabidiol Research Expansion Act, an act aimed at providing federal support to facilitate research of cannabis and its potential health benefits.

Legislation: Who’s Impacted
The medical community, including researchers in the bio-medical field, and those interested in the pharmaceutical applications of cannabis, as well as patients in need of more treatment options. The research will also help inform lawmakers, cannabis businesses, and consumers.

Things to look out for
The S&P500, or the general market, is in an overall bearish trend and showing signs of resistance after a recent 2-month bull rally.

About the company
Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia, and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.